1.71 USD
▼-0.17-9.04%
盘后 1.65 -3.51%
2026-11-20
市值
$3.20M
市盈率
—
EPS
-3.19
股息率
—
52 周区间
1.10 – 10.43
成交量
41.63K
Beta
0.91
目标价
—
52W 低 1.1052W 高 10.43
价格走势
公司简介
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a ...